TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 DKK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
4,289
|
4,160 | |
| Financial expenses |
0
|
241 | |
| Earnings before taxes |
2,978
|
2,576 | |
| EBITDA |
2,717
|
1,345 | |
| Total assets |
14,428
|
12,404 | |
| Current assets |
5,622
|
5,403 | |
| Current liabilities |
1,857
|
1,306 | |
| Equity capital |
12,357
|
10,466 | |
| - share capital |
32
|
34 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
85.6%
|
84.4% | |
| Turnover per employee |
2,144
|
2,080 | |
| Profit as a percentage of turnover |
69.4%
|
61.9% | |
| Return on assets (ROA) |
20.6%
|
22.7% | |
| Current ratio |
302.7%
|
413.7% | |
| Return on equity (ROE) |
24.1%
|
24.6% | |
| Change turnover |
326
|
853 | |
| Change turnover % |
-12%
|
8%
|
26% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.